Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
Journal: The European respiratory journal
Published: February 08, 2021
Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions.
Journal: Respiratory research
Published: December 22, 2020
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 09, 2020
Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
Journal: Respiratory research
Published: September 07, 2020
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: June 30, 2020
Clinical effects of mepolizumab in patients with severe eosinophilic asthma according to background therapy: A meta-analysis.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 04, 2020
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 15, 2020
Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: October 25, 2019
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy.
Journal: The Journal of allergy and clinical immunology
Published: October 23, 2019
Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
Journal: Respiratory medicine
Published: July 23, 2019
Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: June 29, 2019
Usability of mepolizumab single-use prefilled autoinjector for patient self-administration.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: June 29, 2019
Last Updated: 09/26/2026